このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Effects of Neuromuscular Electrical Stimulation With Neural Mobilization in Stroke Patients

2026年6月1日 更新者:Riphah International University

Effects of Neuromuscular Electrical Stimulation Combined With Upper Limb Neural Mobilization on Hand Grip and Range of Motion in Post Stroke Patients

The goal of this clinical trial is to learn if neuromuscular electrical stimulation combined with upper limb neural mobilization works to improve hand grip and upper limb function in post-stroke patients.

調査の概要

詳細な説明

Literature Review: In previous studies researcher compared Dynamic Neural Mobilization and Proprioceptive Neuromuscular Facilitation (PNF) in 30 sub-acute stroke patients, divided into two groups (15 each). Both groups received 30-minute sessions, 5 days/week for 4 weeks. Pre-test FMA-UE scores were 33.60±7.13 (Group A) vs. 32.60±9.85 (Group B), and grip strength 2.92±1.07 kg vs. 1.70±0.68 kg. Post-test scores improved to 41.00±7.07 and 5.12±2.03 kg (Group A), and 34.13±10.40 and 3.32±0.82 kg (Group B). Dynamic Neural Mobilization showed significantly better improvements in both outcomes.

A randomised controlled experiment with forty-three stroke patients who had hemiplegia in order to evaluate the impact of neural mobilisation in conjunction with shoulder control training,. The additional effect of neural mobilisation in stroke rehabilitation was supported by the treatment group's considerably higher improvements in upper limb motor function (FMA-UE) and shoulder pain (NRS) after four weeks when compared to the control group that received only shoulder training.

A qualitative review of 16 studies on neurodynamics in stroke patients, including 9 RCTs, 3 clinical trials, 3 systematic reviews, and 1 case study. Most studies reported that neurodynamics improved range of motion, flexibility, tone reduction, pain, nerve conduction, cortical activity, and post-stroke function. Only one RCT reported no effect on spasticity. Despite these benefits, the review concluded that evidence remains limited and more high-quality research is needed to validate neurodynamic techniques in stroke rehabilitation.

A case study of a 68-year-old male post-stroke patient with right-sided hemiparesis. The patient received Neuromuscular Electrical Stimulation combined with Proprioceptive Neuromuscular Facilitation (PNF) therapy for 4 sessions over 2 weeks. Post-treatment, improvements were noted in muscle strength and reduction of pain during passive flexion of the shoulder, elbow, and knee. The study concluded that Neuromuscular Electrical Stimulation and Proprioceptive Neuromuscular Facilitation (PNF) effectively promote muscle growth, strength, and pain relief in hemiparetic stroke patients.

A systematic review on the effectiveness of Neuromuscular Electrical Stimulation (NMES) for post-stroke spastic hemiparetic limbs. A total of 26 studies were screened, and 9 clinical studies were included (7 upper limb, 2 lower limb). Spasticity was assessed using Modified Ashworth Scale (MAS) and Electromyography. Most studies reported a decrease in spasticity lasting at least two weeks post-intervention. The authors concluded Neuromuscular Electrical Stimulation (NMES) is effective both alone or combined with physical therapy, while recommending further studies on Neuromuscular Electrical Stimulation (NMES) parameters.

A parallel two-arm open-label trial on 26 sub-acute stroke patients using an interactive grasp rehabilitation system (S2) combining smart objects, orthoses, and forearm Neuromuscular Electrical Stimulation (NMES). Participants were block-randomized into experimental (n=14) and control (n=12) groups, receiving 30-minute sessions over 27 sessions. In patients with ARAT scores <35 (n=11), the experimental group showed greater improvement (+14.9 points on ARAT; p=0.0494). The study confirmed the feasibility and effectiveness of enriched Neuromuscular Electrical Stimulation (NMES)-based grasp rehabilitation.

A case study on three first-incident stroke survivors in South Africa to assess the effects of activity-based Neuromuscular Electrical Stimulation (NMES) during short inpatient care. Patients received two 30-minute Neuromuscular Electrical Stimulation (NMES) sessions daily along with occupational therapy for five days. Significant improvements were observed in motor function (FMA, p=0.002) and activities of daily living (MBI, p<0.001), particularly in toilet transfer, hygiene, and washing. Better cognitive function (MMSE scores) was associated with greater outcomes, while age and dominance had less impact.

A randomized controlled trial on 20 tetraplegic patients with upper limb spasticity (C5-C8 level). Participants were randomized into neurodynamic mobilization (n=11) and conventional therapy (n=9) groups, receiving treatment 5 days/week for 4 weeks. Neurodynamic mobilization showed significant improvements: MAS for wrist flexors (-1.64±0.67), finger flexors (-1.00±0.63), F-wave amplitude (-154.09±220.86), F/M ratio (-0.18±0.24), and CUE scores (+17.82±13.49), indicating reduced spasticity and improved upper limb function.

A randomized controlled trial evaluating the effects of neuromuscular electrical stimulation combined with mirror therapy. They reported significant improvements in hand function, motor control, and cortical excitability compared to conventional therapy alone in chronic stroke patients.

In a review of innovative neurotechnologies, that the effect of neuromuscular electrical stimulation (NMES) in regaining motor function following a stroke. According to the study, Neuromuscular Electrical Stimulation (NMES) enhances muscle strength and neuroplasticity, especially when paired with voluntary movement and task-specific training. The authors also go over the advantages of combining Neuromuscular Electrical Stimulation (NMES) with closed-loop systems and brain-machine interfaces to improve the accuracy and results of motor rehabilitation.

A systematic review to assess the status of peripheral neural mechanics and the effect of neural mobilization in stroke rehabilitation. The search across multiple databases identified 22 studies, out of which 12 were included (7 RCTs, 3 quasi-experimental, 1 case report, 1 systematic review). Most studies reported positive therapeutic benefits of neural mobilization, but due to limited methodological quality, the evidence remains weak. The review emphasized the need for further high-quality research on neural mobilization in stroke patients.

Study Gap: Despite the proven benefits of Neuromuscular Electrical Stimulation and neural mobilization in stroke rehabilitation, current literature largely examines these interventions in isolation. To date, up to the researcher's knowledge, no study has directly assessed the combined effects of Neuromuscular Electrical Stimulation and neural mobilization on hand grip strength and upper limb function in post-stroke patients. Additionally, there is limited evidence on standardized protocols for their integration in upper limb rehabilitation.

Given that Neuromuscular Electrical Stimulation targets muscle activation and neural mobilization addresses nerve mobility, combining both may produce synergistic improvements in motor function of upper limb and hand grip. This study aims to fill this gap by evaluating the effectiveness of a combined approach, providing evidence-based strategies for optimizing stroke rehabilitation outcomes.

研究の種類

介入

入学 (推定)

44

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Diagnosed with ischemic stroke (duration ≥ 3 months post-stroke)
  • Patients with hemiparesis affecting the upper limb have a 15-30 score by the Fugl-Meyer Assessment.
  • Medically stable for physical therapy
  • Signed informed consent

Exclusion Criteria:

  • Patients with pacemakers or implanted electrical devices
  • Upper limb fractures or contractures
  • Skin allergies or wounds over the stimulation site
  • Previously taking physiotherapy for the last 3 months.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Control group
Participants in the control group received neural mobilization in combination with conventional physical therapy. Conventional rehabilitation consisted of standardized upper limb exercises, including ROM activities, strengthening exercises, stretching and task oriented training.

Neural mobilization for median, radial, and ulnar nerves. 3 sets of 10 repetitions per nerve for 15 mins with 30 sec rest. Progressed based on tolerance and Range of Motion.

Conventional rehabilitation consisted of standardized upper limb exercises, including ROM activities, strengthening exercises, stretching and tsk oriented training. Each treatment session was conducted for 45 minutes.

他の名前:
  • 伝統的な理学療法
  • 神経動員
実験的:Experimental group
Participants in the experimental group received neuromuscular electrical stimulation combined with upper limb neural mobilization. NMES was administrated using a frequency range of 35-50 Hz and a pulse duration of 250-300 µsec, with an on-off ratio of 1:3. The stimulation intensity was gradually increased until a visible muscle contraction was achieved. Neural mobilization was performed using standardized techniques targeting the median, radial and ulnar nerves.

Neuromuscular Electrical Stimulation (NMES) applied to wrist extensors and finger flexors. Frequency: 35 Hz. Pulse width: 250 µs. Duty cycle: 10s on / 20s off. Intensity: Visible muscle contraction, within patient tolerance. Duration: 30 min Neuromuscular Electrical Stimulation (NMES) + 15 min rest/cool-down.

Neural mobilization for median, radial, and ulnar nerves. 3 sets of 10 repetitions per nerve with 30 sec rest.

他の名前:
  • 神経動員

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Handheld dynamometer
時間枠:Baseline and 6th week
The standard Jamar hydraulic handgrip dynamometer with reliability (ICC = 0.95-0.98) was used according to established ASHT (American Society of Hand Therapists) protocols for the measurement of hand grip strength. The patient was seated with shoulder adducted, elbow flexed at 90°, forearm neutral, and wrist 0-30° extension. A total of three trials (kg) with a 1-minute rest between trials was done, and the mean of the 3 values was recorded.
Baseline and 6th week
Goniometer
時間枠:baseline and 6th week
A clinically accepted instrument with high reliability (ICC: 0.85 - 0.99), in accordance with standardised assessment protocols. Each movement was measured across three trails with a 1-minute rest period between trails, and the average of the three readings (in degrees) was used for statistical analysis.
baseline and 6th week
Fugl-Meyer Assessment - Upper Extremity
時間枠:Baseline and 6th week
The scale assesses motor recovery by observing movement patterns that advance from proximal to distal joints and from mass synergistic actions to more selective, isolated movements following a stroke. It consists of 4 sections: shoulder-arm, wrist, hand, and coordination and speed. It comprises 33 test items, each scored on a three-point ordinal scale (0-2) with a maximum achievable score of 66. In stroke patients the scale has revealed high reliability (ICC: 0.993 - 0.997).
Baseline and 6th week

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Hira Jabeen、Riphah International University
  • 主任研究者:Jabeen、Riphah International University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年6月1日

一次修了 (推定)

2026年6月1日

研究の完了 (推定)

2026年8月1日

試験登録日

最初に提出

2026年6月1日

QC基準を満たした最初の提出物

2026年6月1日

最初の投稿 (実際)

2026年6月5日

学習記録の更新

投稿された最後の更新 (実際)

2026年6月5日

QC基準を満たした最後の更新が送信されました

2026年6月1日

最終確認日

2026年6月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • REC/0235 Fatima Shahid

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

Conventional physical therapyの臨床試験

購読する